CONMED CORP (CNMD) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:CNMD - US2074101013 - Common Stock
CNMD Key Statistics, Chart & Performance
The current stock price of CNMD is 43.49 USD. In the past month the price increased by 8.54%. In the past year, price decreased by -36.81%.
CNMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.61 | 222.19B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.86 | 210.17B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.15 | 144.97B | ||
| SYK | STRYKER CORP | 27.82 | 140.11B | ||
| BDX | BECTON DICKINSON AND CO | 14.24 | 58.61B | ||
| IDXX | IDEXX LABORATORIES INC | 56.05 | 56.44B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.4 | 49.82B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.9 | 39.51B | ||
| RMD | RESMED INC | 25.17 | 36.37B | ||
| DXCM | DEXCOM INC | 37.58 | 27.26B | ||
| PODD | INSULET CORP | 64.41 | 20.71B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.71 | 18.78B |
Related stock screener links
About CNMD
Company Profile
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Company Info
CONMED CORP
11311 Concept Boulevard
Largo FLORIDA 33773 US
CEO: Curt R. Hartman
Employees: 3900
Phone: 17272142974
CONMED CORP / CNMD FAQ
What does CONMED CORP do?
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Can you provide the latest stock price for CONMED CORP?
The current stock price of CNMD is 43.49 USD. The price increased by 3.84% in the last trading session.
Does CONMED CORP pay dividends?
CONMED CORP (CNMD) has a dividend yield of 1.97%. The yearly dividend amount is currently 0.8.
What is the ChartMill rating of CONMED CORP stock?
CNMD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the Price/Earnings (PE) ratio of CONMED CORP (CNMD)?
The PE ratio for CONMED CORP (CNMD) is 9.62. This is based on the reported non-GAAP earnings per share of 4.52 and the current share price of 43.49 USD.
Can you provide the upcoming dividend date for CONMED CORP?
The next ex-dividend date for CONMED CORP (CNMD) is September 15, 2025.
Can you provide the market cap for CONMED CORP?
CONMED CORP (CNMD) has a market capitalization of 1.35B USD. This makes CNMD a Small Cap stock.
CNMD Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CNMD. When comparing the yearly performance of all stocks, CNMD is a bad performer in the overall market: 84.53% of all stocks are doing better.
CNMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to CNMD. While CNMD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
CNMD Financial Highlights
Over the last trailing twelve months CNMD reported a non-GAAP Earnings per Share(EPS) of 4.52. The EPS increased by 16.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.77% | ||
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| Debt/Equity | 0.85 |
CNMD Forecast & Estimates
12 analysts have analysed CNMD and the average price target is 49.37 USD. This implies a price increase of 13.52% is expected in the next year compared to the current price of 43.49.
For the next year, analysts expect an EPS growth of 10.38% and a revenue growth 5.12% for CNMD